Breaks Categories: News

TuesdayJun 24, 2025 3:15 pm

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs, announced new preclinical data showing that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation. The compound demonstrated a dose-dependent and statistically significant reduction in pro-inflammatory cytokines IL-6, IL-1β, IL-2, KC/Gro, and inflammasome marker NLRP3—key factors in Alzheimer’s disease progression. Notably, the effects were independent of amyloid beta or tau pathology, highlighting INM-901’s broader potential in treating neurodegenerative diseases. The orally administered compound also targets CB1/CB2 receptors and PPARs and has shown improvements in cognition and behavior in long-term animal…

Continue Reading

WednesdayMay 28, 2025 12:56 pm

HempNewsBreaks – CannabisNewsWire Named Official Newswire of 2025 Cannabis Means Business Expo in NYC 

CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork (IBN), has been named the official newswire for Cannabis Means Business (CMB) – Conference and Expo, taking place June 4–5, 2025, at the Javits Convention Center in New York City. IBN will also serve as the event’s Official Media Sponsor, supporting CMB—formerly known as CWCBExpo—as it enters its 11th year as a premier networking, education, and business development gathering for the cannabis industry.  CMB 2025 will host entrepreneurs, investors, dispensary operators, cultivators, regulators, and industry influencers for two days of workshops, exhibitions, and world-class programming.…

Continue Reading

WednesdayMar 05, 2025 2:15 pm

HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently announced that it has closed the issuance of $300.0 million of 7.625% senior secured notes due 2032. TPB will use the proceeds to refinance existing notes, pay related fees and expenses and for general corporate purposes. Roth Capital Partners acted as co-manager for the transaction.  For more information about the company, visit https://cnw.fm/IGPUH  About Turning Point Brands Inc.  Turning Point Brands is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic Zig-Zag(R) and…

Continue Reading

FridayDec 27, 2024 12:16 pm

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S., today reviewed highlights and announced future plans in a letter to shareholders. In addition to outlining multiple accomplishments from 2024, the company indicated that it intends “to expand into ‘consumer packaged goods’ utilizing our rare Landrace strains including Original Panama Red, Acapulco Gold, Red Bud Colombian, Santa Marta Gold, African Ebony, Jamaican, Thai (ThaiSticks) and Andalusian Nepalese (remember Temple Balls - Hash),” the letter reads. “As your president and CEO, I’m so very grateful for your support and patience as our team at WEED moves…

Continue Reading

TuesdayDec 17, 2024 2:58 pm

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate purchase and sale of approximately $3.6 million of Common Shares, each at a price of $1.25. Flora announced approximately $3.6 million in expected aggregate gross proceeds from the offering, of which it intends to use the net, together with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Dorsey & Whitney LLP acted as counsel to the company, and Kaufman & Canoles P.C. acted as counsel to Aegis Capital Corp. To view the full…

Continue Reading

ThursdayNov 21, 2024 11:30 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call at 1:30 p.m. PST on Wednesday, Dec. 11, 2024, on the company’s official X account, @GTV_Inc. Steffan Dalsgaard, president of Golden Triangle Ventures and CEO of Lavish Entertainment, alongside Marco Moreno, president of Lavish Entertainment, will lead the event and deliver a comprehensive update on the company’s transformative flagship project — Destino Ranch. GTV’s wholly owned subsidiary Lavish Entertainment is spearheading the development of Destino Ranch, which is poised to become a world-renowned destination and premier experiential hospitality and entertainment venue, including immersive art installations,…

Continue Reading

ThursdayOct 24, 2024 12:45 pm

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70 billion industry and, with its innovative product line and strategic market positioning, standing ready to deliver unparalleled returns for shareholders. “The U.S. is on the verge of a historic shift. With the Biden administration, led by Vice President Kamala Harris, taking bold steps toward federal marijuana legalization, the opportunities for companies in the cannabis and CBD sectors are poised to skyrocket,” the announcement reads. “According to industry projections, the legal cannabis market in the U.S. is expected to surpass $70 billion by 2028, driven by…

Continue Reading

FridaySep 27, 2024 3:20 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that it had received approval from an independent review board for its planned human pilot study #3. The approval signals that the company can begin the study, which aims to investigate the first ever DehydraTECH-processed version of tirzepatide, a dual action glucagon-like peptide (“GLP-1”) + glucose-dependent insulinotropic peptide (“GIP”), in an oral dose format. Tirzepatide is approved for use in the U.S. under the Eli Lilly(TM)-owned Zepbound(R) and Mounjaro(R) brands. Lexaria plans to begin subject enrollment shortly, with the company expecting to make an announcement as…

Continue Reading

FridaySep 20, 2024 1:21 pm

HempNewsBreaks – Cannabis Conference and Expo Creates Key Opportunity for Cannabis Innovation to Meet Cannabis Community

Cannabis Conference and Expo: Grow Up 2024 will be held in Edmonton, Alberta, later this month. The three-day event is slated for Sept. 29–Oct. 1, 2024, and will bring together top growers, the largest cannabis brands and thousands of delegates for an invaluable conference and trade show designed to provide key information about relevant topics in the cannabis industry. The event is Canada’s largest conference and expo. The event agenda features an exclusive riverboat kick-off party, expo days, a Canadian cannabis championship, an array of addresses, panel presentations and workshops by industry experts and an insightful interview with legendary cannabis…

Continue Reading

ThursdaySep 12, 2024 2:08 pm

HempNewsBreaks – CannabisNewsWire and IBN Partner with NY Cannabis Insider to Boost Visibility for Premier Cannabis Event

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 65+ brands powered by IBN, on Thursday announced that it has been named the Official NewsWire of the NY Cannabis Insider event, with IBN serving as the Official Media Sponsor. The event, scheduled for September 25, 2024, at The Desmond Hotel in Albany, NY, will focus on "Making Money in the Legal NYS Market," featuring industry leaders sharing insights on building profitable cannabis businesses. CNW will amplify the event’s coverage through its vast syndication network, while IBN will drive visibility across its family of brands. This…

Continue Reading